Yu‐Chun Weng

580 total citations
22 papers, 418 citations indexed

About

Yu‐Chun Weng is a scholar working on Molecular Biology, Obstetrics and Gynecology and Cancer Research. According to data from OpenAlex, Yu‐Chun Weng has authored 22 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Obstetrics and Gynecology and 6 papers in Cancer Research. Recurrent topics in Yu‐Chun Weng's work include Epigenetics and DNA Methylation (8 papers), Cancer-related molecular mechanisms research (6 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Yu‐Chun Weng is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Cancer-related molecular mechanisms research (6 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Yu‐Chun Weng collaborates with scholars based in Taiwan, China and Vietnam. Yu‐Chun Weng's co-authors include Hung‐Cheng Lai, Rui Huang, Po‐Hsuan Su, Hui-Chen Wang, Yu-Ping Liao, Phui‐Ly Liew, Tzu-I Wu, Tai‐Kuang Chao, Cheng‐Chang Chang and Lin‐Yu Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Yu‐Chun Weng

22 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Chun Weng Taiwan 10 261 126 79 65 59 22 418
Ruixiu Zhang China 10 272 1.0× 138 1.1× 31 0.4× 38 0.6× 202 3.4× 18 492
Chieh-Yang Cheng Taiwan 8 385 1.5× 133 1.1× 31 0.4× 115 1.8× 185 3.1× 12 611
Akiyo Ogawa United States 8 168 0.6× 77 0.6× 35 0.4× 55 0.8× 80 1.4× 9 339
Elangovan Thavathiru United States 12 219 0.8× 59 0.5× 20 0.3× 28 0.4× 92 1.6× 16 371
Hiroe Nakamura Japan 12 182 0.7× 113 0.9× 17 0.2× 29 0.4× 124 2.1× 29 365
Keng Shen China 13 455 1.7× 309 2.5× 17 0.2× 105 1.6× 92 1.6× 40 602
Yu Dai China 10 263 1.0× 83 0.7× 18 0.2× 19 0.3× 68 1.2× 21 449
Zhen Yuan China 11 175 0.7× 111 0.9× 23 0.3× 25 0.4× 58 1.0× 28 335
Shunji Kamazawa Japan 9 185 0.7× 65 0.5× 24 0.3× 132 2.0× 177 3.0× 13 371
Ulrika W. Nilsson Sweden 9 196 0.8× 128 1.0× 14 0.2× 25 0.4× 89 1.5× 10 398

Countries citing papers authored by Yu‐Chun Weng

Since Specialization
Citations

This map shows the geographic impact of Yu‐Chun Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Chun Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Chun Weng more than expected).

Fields of papers citing papers by Yu‐Chun Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Chun Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Chun Weng. The network helps show where Yu‐Chun Weng may publish in the future.

Co-authorship network of co-authors of Yu‐Chun Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Chun Weng. A scholar is included among the top collaborators of Yu‐Chun Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Chun Weng. Yu‐Chun Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Lin‐Yu, Yu‐Ting Chou, Phui‐Ly Liew, et al.. (2024). In vitro drug testing using patient-derived ovarian cancer organoids. Journal of Ovarian Research. 17(1). 194–194. 2 indexed citations
2.
Chen, Lin‐Yu, Yao Shen, Po‐Hsuan Su, et al.. (2024). Active DNA Demethylase, TET1, Increases Oxidative Phosphorylation and Sensitizes Ovarian Cancer Stem Cells to Mitochondrial Complex I Inhibitor. Antioxidants. 13(6). 735–735. 2 indexed citations
3.
Su, Po‐Hsuan, Chii‐Ruey Tzeng, Chi‐Huang Chen, et al.. (2023). Cervical Secretion Methylation Is Associated with the Pregnancy Outcome of Frozen-Thawed Embryo Transfer. International Journal of Molecular Sciences. 24(2). 1726–1726. 2 indexed citations
4.
Su, Po‐Hsuan, et al.. (2023). DNA Methylation of Window of Implantation Genes in Cervical Secretions Predicts Ongoing Pregnancy in Infertility Treatment. International Journal of Molecular Sciences. 24(6). 5598–5598. 7 indexed citations
5.
Wen, Kuo‐Chang, Rui Huang, Lin‐Yu Chen, et al.. (2022). Endometrial Cancer Detection Using a Cervical DNA Methylation Assay (MPap) in Women with Abnormal Uterine Bleeding: A Multicenter Hospital-Based Validation Study. Cancers. 14(17). 4343–4343. 9 indexed citations
6.
Chen, Lin‐Yu, Po‐Hsuan Su, Phui‐Ly Liew, et al.. (2022). BHLHE22 Expression Is Associated with a Proinflammatory Immune Microenvironment and Confers a Favorable Prognosis in Endometrial Cancer. International Journal of Molecular Sciences. 23(13). 7158–7158. 6 indexed citations
7.
Chen, Lin‐Yu, Rui Huang, Po‐Hsuan Su, et al.. (2022). Epigenomic Profiling of Epithelial Ovarian Cancer Stem-Cell Differentiation Reveals GPD1 Associated Immune Suppressive Microenvironment and Poor Prognosis. International Journal of Molecular Sciences. 23(9). 5120–5120. 6 indexed citations
8.
9.
Liew, Phui‐Ly, Rui Huang, Tzu-I Wu, et al.. (2019). Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings. Clinical Epigenetics. 11(1). 170–170. 38 indexed citations
10.
Chen, Lin‐Yu, Rui Huang, Michael WY Chan, et al.. (2019). TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target. The Journal of Pathology. 248(3). 363–376. 29 indexed citations
11.
Huang, Rui, Phui‐Ly Liew, Po‐Hsuan Su, et al.. (2018). GATA3 as a master regulator and therapeutic target in ovarian high‐grade serous carcinoma stem cells. International Journal of Cancer. 143(12). 3106–3119. 32 indexed citations
12.
Huang, Rui, Lin‐Yu Chen, Tai‐Kuang Chao, et al.. (2018). Epigenetic loss of heparan sulfate 3‐O‐sulfation sensitizes ovarian carcinoma to oncogenic signals and predicts prognosis. International Journal of Cancer. 143(8). 1943–1953. 9 indexed citations
13.
Liew, Phui‐Ly, Rui Huang, Yu‐Chun Weng, et al.. (2018). Distinct methylation profile of mucinous ovarian carcinoma reveals susceptibility to proteasome inhibitors. International Journal of Cancer. 143(2). 355–367. 14 indexed citations
14.
Chang, Cheng‐Chang, Hui-Chen Wang, Yu-Ping Liao, et al.. (2017). The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings. Journal of Gynecologic Oncology. 29(1). e17–e17. 39 indexed citations
15.
Su, Po‐Hsuan, Rui Huang, Yu‐Chun Weng, et al.. (2017). Methylomics of nitroxidative stress on precancerous cells reveals DNA methylation alteration at the transition from in situ to invasive cervical cancer. Oncotarget. 8(39). 65281–65291. 11 indexed citations
16.
Chen, Ying, Da-Chen Chu, Yu‐Chun Weng, et al.. (2017). Identification and preclinical evaluation of the small molecule, NSC745887, for treating glioblastomas via suppressing DcR3-associated signaling pathways. Oncotarget. 9(15). 11922–11937. 6 indexed citations
17.
Huang, Rui, Po‐Hsuan Su, Yu-Ping Liao, et al.. (2016). Integrated Epigenomics Analysis Reveals a DNA Methylation Panel for Endometrial Cancer Detection Using Cervical Scrapings. Clinical Cancer Research. 23(1). 263–272. 65 indexed citations
18.
Ma, Kuo-Hsing, et al.. (2016). Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [123I]-ADAM/SPECT. Scientific Reports. 6(1). 38695–38695. 7 indexed citations
19.
Weng, Yu‐Chun, et al.. (2015). Effect of MDMA-Induced Axotomy on the Dorsal Raphe Forebrain Tract in Rats: An In Vivo Manganese-Enhanced Magnetic Resonance Imaging Study. PLoS ONE. 10(9). e0138431–e0138431. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruixiu Zhang Breakdown of academic impact, for papers by Chieh-Yang Cheng Breakdown of academic impact, for papers by Akiyo Ogawa Breakdown of academic impact, for papers by Elangovan Thavathiru Breakdown of academic impact, for papers by Hiroe Nakamura Breakdown of academic impact, for papers by Keng Shen Breakdown of academic impact, for papers by Yu Dai Breakdown of academic impact, for papers by Zhen Yuan Breakdown of academic impact, for papers by Shunji Kamazawa Breakdown of academic impact, for papers by Ulrika W. Nilsson
Rankless by CCL
2026